Overview

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
To assess the acute and long-term bimodal efficacy of QTP, as an adjunct to ongoing treatment with lithium (Li) or divalproex (DIV) or lamotrigine (LAM) or any combination of the three thereof, in a group of patients with an index episode of a mixed state in BD.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborator:
AstraZeneca
Treatments:
Quetiapine Fumarate